AuntMinnie.com staff writersAILunit completes $193M acquisition of VolparaLunitLunit has completed a $193 million acquisition of breast and lung imaging software firm Volpara Health Technologies.May 22, 2024AIGE HealthCare leads on list of AI devicesGE HealthCareGE HealthCare topped a list of AI-enabled medical devices to receive 510(k) clearance by the U.S. Food and Drug Administration (FDA).May 22, 2024Radiation Oncology/TherapyAktis inks potential $1B deal with Eli LillyAktis Oncology has entered a potential $1 billion agreement with Eli Lilly to generate anticancer radiopharmaceuticals.May 22, 2024People in the NewsDelphinus appoints Gundlapalli to VP roleDelphinus Medical Technologies has appointed Rama Gundlapalli as its vice president (VP) of engineering.May 21, 2024Molecular ImagingLantheus appoints new CMO, CSOLantheus Medical Imaging has appointed a new chief medical officer (CMO) and chief science officer (CSO).May 20, 2024CTBrainomix celebrates FDA clearance for e-LungEntry into the lung imaging space expands the company's footprint in medical imaging beyond its stroke-related applications.May 17, 2024Womens ImagingIbex, Metaltronica to combine mammography, osteoporosis screeningCombining osteoporosis screening with mammography may be beneficial for post-menopausal women and those undergoing breast cancer treatment using aromatase inhibitors.May 17, 2024Radiation Oncology/TherapyRaySearch posts sales increase in Q1RaySearch Laboratories more than doubled its profit after tax compared to 2023's first quarter.May 17, 2024Radiation Oncology/TherapyRegistration open for ASTRO 2024 annual meetingRegistration is open for the American Society for Radiation Oncology's (ASTRO) 66th annual meeting, which will be held in Washington, D.C.May 16, 2024Imaging LeadersMerit appoints Joe Wright as presidentMerit MedicalMerit Medical Systems has appointed Joe Wright as company president, effective immediately.May 16, 2024Previous PagePage 171 of 236Next PageTop StoriesNuclear MedicineGenetic mutations linked to poor outcomes in Pluvicto patientsTP53, PTEN, and RB1 mutations may serve as prognostic biomarkers.Womens ImagingAI support leads to more cancers found on DBTCTPROMISE: Women face higher heart disease risk at lower plaque burdensMolecular ImagingPET predicts faster cognitive decline in women than menSponsor ContentHow Agentic AI Is Transforming Radiology Ops